Prediction of Drug-Drug Interactions for Highly Plasma Protein Bound Compounds
Crossref DOI link: https://doi.org/10.1208/s12248-024-00987-7
Published Online: 2024-12-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tess, David
Harrison, Makayla
Lin, Jian
Li, Rui
Di, Li https://orcid.org/0000-0001-6117-9022
Text and Data Mining valid from 2024-12-12
Version of Record valid from 2024-12-12
Article History
Received: 19 August 2024
Accepted: 21 October 2024
First Online: 12 December 2024
Declarations
:
: Authors are employees of Pfizer Inc., New York, NY, USA, and may hold Pfizer stocks.